Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Verhoogd risico op pancreascarcinoom na HCV-infectie
dec 2025 | Hepatitis, Maag-darm-leveroncologie, Virale infecties